dilazep has been researched along with Leg Ulcer in 1 studies
Dilazep: Coronary vasodilator with some antiarrhythmic activity.
dilazep : A member of the class of diazepanes that is 1,4-diazepane substituted by 3-[(3,4,5-trimethoxybenzoyl)oxy]propyl groups at positions 1 and 4. It is a potent adenosine uptake inhibitor that exhibits antiplatelet, antianginal and vasodilator properties.
Leg Ulcer: Ulceration of the skin and underlying structures of the lower extremity. About 90% of the cases are due to venous insufficiency (VARICOSE ULCER), 5% to arterial disease, and the remaining 5% to other causes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Since the obtained results from the pilot study indicated that dilazep which was a membrane stabilizer would be benefit to treatment and prevention of anemia and chronic leg ulcer in beta-thalassemia/hemoglobin E (beta-thal/HbE) patients, the authors had continued the study in a second phase, ie a double blind placebo control trial." | 9.08 | A double-blind placebo control trial of dilazep in beta-thalassemia/hemoglobin E patients. ( Fucharoen, S; Funahara, Y; Imai, K; Opartkiattikul, N; Sangtawesin, W; Sukpanichnant, S; Sumiyoshi, A; Thientadakul, P; Wanachiwanawin, W, 1997) |
| "Since the obtained results from the pilot study indicated that dilazep which was a membrane stabilizer would be benefit to treatment and prevention of anemia and chronic leg ulcer in beta-thalassemia/hemoglobin E (beta-thal/HbE) patients, the authors had continued the study in a second phase, ie a double blind placebo control trial." | 5.08 | A double-blind placebo control trial of dilazep in beta-thalassemia/hemoglobin E patients. ( Fucharoen, S; Funahara, Y; Imai, K; Opartkiattikul, N; Sangtawesin, W; Sukpanichnant, S; Sumiyoshi, A; Thientadakul, P; Wanachiwanawin, W, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Opartkiattikul, N | 1 |
| Sukpanichnant, S | 1 |
| Wanachiwanawin, W | 1 |
| Fucharoen, S | 1 |
| Funahara, Y | 1 |
| Sumiyoshi, A | 1 |
| Imai, K | 1 |
| Sangtawesin, W | 1 |
| Thientadakul, P | 1 |
1 trial available for dilazep and Leg Ulcer
| Article | Year |
|---|---|
A double-blind placebo control trial of dilazep in beta-thalassemia/hemoglobin E patients.
Topics: Adult; beta-Thalassemia; Blood Transfusion; Dilazep; Double-Blind Method; Female; Hemoglobin E; Hemo | 1997 |